INmune Bio
INMB
INMB
33 hedge funds and large institutions have $15.5M invested in INmune Bio in 2021 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
3% more capital invested
Capital invested by funds: $15M → $15.5M (+$515K)
Holders
33
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$2.36M | |
| 2 | +$716K | |
| 3 | +$499K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$393K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$323K |
Top Sellers
| 1 | -$215K | |
| 2 | -$156K | |
| 3 | -$34K | |
| 4 |
CAAS
Capital Asset Advisory Services
Williamston,
Michigan
|
-$32K |
| 5 |
Barclays
London,
United Kingdom
|
-$13.7K |